Annual Drug Patent Expirations for ANNOVERA
Annovera is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
The generic ingredient in ANNOVERA is ethinyl estradiol; segesterone acetate. One supplier is listed for this compound. Additional details are available on the ethinyl estradiol; segesterone acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
